OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting IGF2BP3 in Cancer
Xin Liu, Jiayu Chen, Wenliang Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9423-9423
Open Access | Times Cited: 25
Xin Liu, Jiayu Chen, Wenliang Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9423-9423
Open Access | Times Cited: 25
Showing 25 citing articles:
RNA BINDING PROTEINS (RBPs) ON GENETIC STABILITY AND DISEASES
Abdullahi Tunde Aborode, Ohilebo Abdulateef Abass, Shaibu Nasiru, et al.
Global Medical Genetics (2025) Vol. 12, Iss. 1, pp. 100032-100032
Open Access
Abdullahi Tunde Aborode, Ohilebo Abdulateef Abass, Shaibu Nasiru, et al.
Global Medical Genetics (2025) Vol. 12, Iss. 1, pp. 100032-100032
Open Access
Comprehensive analysis of ceRNA Networks in UCEC: Prognostic and therapeutic implications
Li Fan, Mengqiu Lan, Xiaohua Wei, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0314314-e0314314
Open Access
Li Fan, Mengqiu Lan, Xiaohua Wei, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0314314-e0314314
Open Access
Nitidine chloride inhibits the progression of hepatocellular carcinoma by suppressing IGF2BP3 and modulates metabolic pathways in an m6A-dependent manner
Dandan Xiong, Zhen-dong Chen, Jian-di Li, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Dandan Xiong, Zhen-dong Chen, Jian-di Li, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Pharmacology of Epitranscriptomic Modifications: Decoding the Therapeutic Potential of RNA Modifications in Drug Resistance
Abdullah Alkhammash
European Journal of Pharmacology (2025) Vol. 994, pp. 177397-177397
Closed Access
Abdullah Alkhammash
European Journal of Pharmacology (2025) Vol. 994, pp. 177397-177397
Closed Access
IGF2BP3-mediated regulation of GLS and GLUD1 gene expression promotes treg-induced immune escape in human cervical cancer.
Tiantian Zhou, Ziyi Xiao, Lu Jin, et al.
PubMed (2023) Vol. 13, Iss. 11, pp. 5289-5305
Closed Access | Times Cited: 11
Tiantian Zhou, Ziyi Xiao, Lu Jin, et al.
PubMed (2023) Vol. 13, Iss. 11, pp. 5289-5305
Closed Access | Times Cited: 11
N6-Methyladenosine methylation modification in breast cancer: current insights
Guangwen Zhang, Cheng Chen, Xinle Wang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Guangwen Zhang, Cheng Chen, Xinle Wang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Unraveling the landscape of m6A RNA methylation in wound healing and scars
Qi Zhang, Liming Dong, Song Gong, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Qi Zhang, Liming Dong, Song Gong, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Construction of dual functional CuAl-LDHs nanocomposite loaded with IGF2BP3 siRNA for enhanced therapy of gastric cancer
Haiping Li, Yuying Zhang, Bo Huang, et al.
Chemical Engineering Journal (2024) Vol. 485, pp. 149961-149961
Closed Access | Times Cited: 1
Haiping Li, Yuying Zhang, Bo Huang, et al.
Chemical Engineering Journal (2024) Vol. 485, pp. 149961-149961
Closed Access | Times Cited: 1
IGF2BP3 suppresses ferroptosis in lung adenocarcinoma by m6A-dependent regulation of TFAP2A to transcriptionally activate SLC7A11/GPX4
Pengpeng Li, Dan Chu, Guangcheng Ding, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 1
Pengpeng Li, Dan Chu, Guangcheng Ding, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 1
m6A modification of CDC5L promotes lung adenocarcinoma progression through transcriptionally regulating WNT7B expression
Nanding Yu, Yingxiao Wu, Qiongying Wei, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 7, pp. 3565-3583
Closed Access | Times Cited: 1
Nanding Yu, Yingxiao Wu, Qiongying Wei, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 7, pp. 3565-3583
Closed Access | Times Cited: 1
METTL14-mediated m6A mRNA modification of G6PD promotes lung adenocarcinoma
Weidong Wu, Mengling Li, Yingxiao Wu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Weidong Wu, Mengling Li, Yingxiao Wu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
IGF2BP3 boosts lactate generation to accelerate gastric cancer immune evasion
Kai‐Hsin Lin, Xiufeng Lin, Fan Luo
APOPTOSIS (2024) Vol. 29, Iss. 11-12, pp. 2147-2160
Closed Access | Times Cited: 1
Kai‐Hsin Lin, Xiufeng Lin, Fan Luo
APOPTOSIS (2024) Vol. 29, Iss. 11-12, pp. 2147-2160
Closed Access | Times Cited: 1
IGF2BP3/CTCF Axis–Dependent NT5DC2 Promotes M2 Macrophage Polarization to Enhance the Malignant Progression of Lung Squamous Cell Carcinomas
Jifeng Sun, Hao Wang, Ran Zhang, et al.
The Clinical Respiratory Journal (2024) Vol. 18, Iss. 11
Open Access | Times Cited: 1
Jifeng Sun, Hao Wang, Ran Zhang, et al.
The Clinical Respiratory Journal (2024) Vol. 18, Iss. 11
Open Access | Times Cited: 1
Signaling pathways and targeted therapies in Ewing sarcoma
Jia Ke, Li Cao, Yihan Yu, et al.
Pharmacology & Therapeutics (2024) Vol. 266, pp. 108765-108765
Open Access | Times Cited: 1
Jia Ke, Li Cao, Yihan Yu, et al.
Pharmacology & Therapeutics (2024) Vol. 266, pp. 108765-108765
Open Access | Times Cited: 1
Novel Therapeutic Targets in Cancers
Elena Levantini
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14660-14660
Open Access | Times Cited: 4
Elena Levantini
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14660-14660
Open Access | Times Cited: 4
Bioinformatic identification reveals a m6A-binding protein, IGF2BP2, as a novel tumor-promoting gene signature in thyroid carcinoma
Yang Xie, Junqi Xiao, Yong Ying, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 5663-5676
Closed Access
Yang Xie, Junqi Xiao, Yong Ying, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 5663-5676
Closed Access
A comprehensive review of m 6 A research in cervical cancer
Jing Hu, Shizhi Wang, Xiuting Li
Epigenomics (2024) Vol. 16, Iss. 10, pp. 753-773
Closed Access
Jing Hu, Shizhi Wang, Xiuting Li
Epigenomics (2024) Vol. 16, Iss. 10, pp. 753-773
Closed Access
Drug repositioning in thyroid cancer: from point mutations to gene fusions
David Sánchez-Marín, Macrina Beatriz Silva-Cázares, Manuel González‐Del Carmen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
David Sánchez-Marín, Macrina Beatriz Silva-Cázares, Manuel González‐Del Carmen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
The m6A reader IGF2BP3 promotes gastric cancer progression via increasing the expression of FBXO32 protein
Yi Si, Bo Tian, Rui Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Yi Si, Bo Tian, Rui Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
IGF2BP3 regulates macrophage-induced inflammation and liver damage in acute-on-chronic liver failure via the RORα-NF-κB signaling axis
K.Y. Cheng, Kai Liu, Shu Liu, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113030-113030
Closed Access
K.Y. Cheng, Kai Liu, Shu Liu, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113030-113030
Closed Access
Unveiling the role of IGF1R in autism spectrum disorder: a multi-omics approach to decipher common pathogenic mechanisms in the IGF signaling pathway
Kang Yang, Tian Zhang, Rui‐Ze Niu, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Kang Yang, Tian Zhang, Rui‐Ze Niu, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Deciphering the IGF2BP3-mediated control of ferroptosis: mechanistic insights and therapeutic prospects
Wenjuan Zhang, Hongxing Liu, Changrong Ren, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Wenjuan Zhang, Hongxing Liu, Changrong Ren, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
DNA methylation is a key determinant of response to targeted and immune checkpoint therapies in metastatic renal cell carcinoma
Florian Jeanneret, Sarah Schoch, Pedro J. Ballester, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Florian Jeanneret, Sarah Schoch, Pedro J. Ballester, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Enterolactone combined with m6A Reader IGF2BP3 inhibits Malignant Angiogenesis and Disease Progression in Ovarian Cancer
Mengzhi Xu, Yi Guo, Fengge Wang, et al.
Phytomedicine (2024) Vol. 136, pp. 156343-156343
Closed Access
Mengzhi Xu, Yi Guo, Fengge Wang, et al.
Phytomedicine (2024) Vol. 136, pp. 156343-156343
Closed Access
The Role of tRNA-Derived Small RNAs (tsRNAs) in Pancreatic Cancer and Acute Pancreatitis
Yan Pan, Xiaowei Ying, Xueting Zhang, et al.
Non-coding RNA Research (2024) Vol. 11, pp. 200-208
Open Access
Yan Pan, Xiaowei Ying, Xueting Zhang, et al.
Non-coding RNA Research (2024) Vol. 11, pp. 200-208
Open Access
